The Impact of Non-Compliance to a Standardized Risk-Adjusted Protocol on Recurrence, Progression, and Mortality in Non-Muscle Invasive Bladder Cancer.
Faris AbushammaZain KhayyatAya SoroghleSa'ed H ZyoudAhmad F JaradatMaha AkkawiHanood AburassIyad K K QaddumiRazan OdehHusam SalamehSalah AlbuheissiPublished in: Cancer management and research (2021)
Non-compliance to a standardized surveillance protocol in NMIBC is associated statistically and clinically with adverse outcomes in comparison to a compliant group. This mandates strict adherence to surveillance guidelines particularly in patients with high-risk disease.